Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Accuracy, limits, and approximation01:28

Accuracy, limits, and approximation

1.1K
Accuracy, limits, and approximations are common in many fields, especially in engineering calculations. These concepts are imperative for ensuring that a given value is as close as possible to its true value.
Accuracy is defined as the closeness of the measured value to the true or actual value. In engineering mechanics, repeated measurements are taken during theoretical or experimental analyses to ensure that the result is precise and accurate.
The accuracy of any solution is based on the...
1.1K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

241
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
241
Design Example: Underdamped Parallel RLC Circuit01:17

Design Example: Underdamped Parallel RLC Circuit

635
Consider designing an oscillator circuit, a crucial component in various electronic devices and systems. The objective is to create an oscillator circuit with specific characteristics: a damped natural frequency of 4 kHz and a damping factor of 4 radians per second. To accomplish this, a parallel RLC circuit is employed, known for its ability to sustain oscillations at a resonant frequency. In this case, the damping factor is pivotal in achieving the desired performance.
Starting with a fixed...
635
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

188
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
188
Confidence Coefficient01:24

Confidence Coefficient

10.5K
The confidence coefficient is also known as the confidence level or degree of confidence. It is the percent expression for the probability, 1-α, that the confidence interval contains the true population parameter assuming that the confidence interval is obtained after sufficient unbiased sampling; for example, if the CL = 90%, then in 90 out of 100 samples the interval estimate will enclose the true population parameter. Here α is the area under the curve, distributed equally under...
10.5K
Bioequivalence: Overview01:16

Bioequivalence: Overview

1.9K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Construction and prototype effect evaluation of a multi-agent collaborative system for operating room nursing.

Frontiers in digital health·2026
Same author

Risk factors of inflammatory bowel disease complicating anemia: A systematic review and meta-analysis.

Medicine·2026
Same author

New Reversible Covalent Warheads: Cyanobenzothiazoles Recruiting DCAF16 for Targeted Protein Degradation.

Journal of medicinal chemistry·2026
Same author

Roles of peroxisome proliferator-activated receptors (PPARs) in pancreatic metabolic diseases.

Pharmacological research·2026
Same author

Attention focus modulates motor performance and frontoparietal connectivity: an fNIRS study.

Experimental brain research·2026
Same author

Latent profile analysis of self-efficacy in information security and positive coping level among nursing students: a multicenter cross-sectional study in China.

Frontiers in psychology·2026

Related Experiment Video

Updated: Jan 20, 2026

Mesocosm-Scale Constructed Wetland Design for Wastewater Treatment
08:24

Mesocosm-Scale Constructed Wetland Design for Wastewater Treatment

Published on: May 2, 2025

892

Approximate confidence limit for the reference scaled bioequivalence with a parallel design.

Jason J Z Liao1, Yifang Li2

  • 1Biostatistics and Research Decision Sciences, Merck & Co., Inc, North Wales, PA, USA.

Journal of Biopharmaceutical Statistics
|August 29, 2019
PubMed
Summary
This summary is machine-generated.

This study introduces a new statistical method for reference scaled bioequivalence in parallel designs, crucial for biosimilar development. The approximation offers reliable results for highly variable products, ensuring accuracy and cost-effectiveness.

Keywords:
Linearized criterionparallel designreference scaled bioequivalenceupper limit

More Related Videos

In Situ Lithiated Reference Electrode: Four Electrode Design for In-operando Impedance Spectroscopy
09:36

In Situ Lithiated Reference Electrode: Four Electrode Design for In-operando Impedance Spectroscopy

Published on: September 12, 2018

9.2K
Setting Limits on Supersymmetry Using Simplified Models
07:46

Setting Limits on Supersymmetry Using Simplified Models

Published on: November 15, 2013

8.9K

Related Experiment Videos

Last Updated: Jan 20, 2026

Mesocosm-Scale Constructed Wetland Design for Wastewater Treatment
08:24

Mesocosm-Scale Constructed Wetland Design for Wastewater Treatment

Published on: May 2, 2025

892
In Situ Lithiated Reference Electrode: Four Electrode Design for In-operando Impedance Spectroscopy
09:36

In Situ Lithiated Reference Electrode: Four Electrode Design for In-operando Impedance Spectroscopy

Published on: September 12, 2018

9.2K
Setting Limits on Supersymmetry Using Simplified Models
07:46

Setting Limits on Supersymmetry Using Simplified Models

Published on: November 15, 2013

8.9K

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Biostatistics
  • Drug Development

Background:

  • Reference scaled bioequivalence is effective for highly variable products.
  • Crossover designs are common but not always feasible, especially for biosimilar studies.
  • Parallel designs offer a more timely and cost-effective alternative.

Purpose of the Study:

  • To derive an approximate upper confidence interval limit for the linearized criteria in reference scaled bioequivalence using a parallel design.
  • To evaluate the performance of this approximation through simulations.

Main Methods:

  • Derivation of an approximate upper confidence interval limit.
  • Statistical analysis of reference scaled bioequivalence.
  • Simulation studies to evaluate performance.

Main Results:

  • The derived approximation performs well in simulations.
  • The method provides reasonable statistical power.
  • Type I error rates are well-controlled.

Conclusions:

  • The approximate upper confidence interval limit for reference scaled bioequivalence in parallel designs is a viable statistical tool.
  • This method is suitable for applications where crossover designs are not feasible, such as biosimilar studies.
  • The simulation results support the reliability and practicality of the proposed approximation.